Recent advances in clinical practice: management of inflammatory bowel disease during the COVID-19 pandemic
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Recent advances in clinical practice: management of inflammatory bowel disease during the COVID-19 pandemic
Authors
Keywords
-
Journal
GUT
Volume -, Issue -, Pages gutjnl-2021-326784
Publisher
BMJ
Online
2022-05-24
DOI
10.1136/gutjnl-2021-326784
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Outcomes of COVID-19 in Patients with Inflammatory Bowel Disease: Comparison with Household Members and the Role of IBD Medications
- (2022) Ali Reza Sima et al. Archives of Iranian Medicine
- Effectiveness and Durability of COVID-19 Vaccination in 9447 Patients with IBD: A Systematic Review and Meta-Analysis
- (2022) Anuraag Jena et al. Clinical Gastroenterology and Hepatology
- Gut microbiota dynamics in a prospective cohort of patients with post-acute COVID-19 syndrome
- (2022) Qin Liu et al. GUT
- DOP27 Humoral immune response after SARS-CoV-2 vaccination in patients with immune-mediated inflammatory diseases treated with immunosuppressive therapy - a Target to B! study
- (2022) A Volkers et al. Journal of Crohns & Colitis
- Considerable escape of SARS-CoV-2 Omicron to antibody neutralization
- (2022) Delphine Planas et al. NATURE
- COVID-19 vaccine-induced antibody responses in immunosuppressed patients with inflammatory bowel disease (VIP): a multicentre, prospective, case-control study
- (2022) James L Alexander et al. Lancet Gastroenterology & Hepatology
- Ambulatory care management of 69 patients with acute severe ulcerative colitis in comparison to 695 inpatients: insights from a multicentre UK cohort study
- (2022) Shaji Sebastian et al. BMJ Open Gastroenterology
- Antibody decay, T cell immunity and breakthrough infections following two SARS-CoV-2 vaccine doses in inflammatory bowel disease patients treated with infliximab and vedolizumab
- (2022) Simeng Lin et al. Nature Communications
- SARS-COV-2 INFECTION AND SEROCONVERSION IN PEDIATRIC INFLAMMATORY BOWEL DISEASE PATIENTS
- (2021) Wenly Ruan et al. INFLAMMATORY BOWEL DISEASES
- 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study
- (2021) Chaolin Huang et al. LANCET
- Discordant neutralizing antibody and T cell responses in asymptomatic and mild SARS-CoV-2 infection
- (2021) Catherine J. Reynolds et al. Science Immunology
- From intravenous to subcutaneous infliximab in patients with inflammatory bowel disease: a pandemic-driven initiative
- (2021) Ajay M Verma et al. Lancet Gastroenterology & Hepatology
- Predicting endoscopic activity recovery in England after COVID-19: a national analysis
- (2021) Kai Man Alexander Ho et al. Lancet Gastroenterology & Hepatology
- Serological response to mRNA COVID-19 vaccines in IBD patients receiving biological therapies
- (2021) Serre-Yu Wong et al. GASTROENTEROLOGY
- Risk factors for SARS-CoV-2 infection and course of COVID-19 disease in patients with IBD in the Veterans Affair Healthcare System
- (2021) Nabeel Khan et al. GUT
- Infliximab is associated with attenuated immunogenicity to BNT162b2 and ChAdOx1 nCoV-19 SARS-CoV-2 vaccines in patients with IBD
- (2021) Nicholas A Kennedy et al. GUT
- Anti-SARS-CoV-2 antibody responses are attenuated in patients with IBD treated with infliximab
- (2021) Nicholas A Kennedy et al. GUT
- The impact of vedolizumab on COVID-19 outcomes among adult IBD patients in the SECURE-IBD registry
- (2021) Manasi Agrawal et al. Journal of Crohns & Colitis
- Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection
- (2021) David S. Khoury et al. NATURE MEDICINE
- Antibody responses to the BNT162b2 mRNA vaccine in individuals previously infected with SARS-CoV-2
- (2021) Joseph E. Ebinger et al. NATURE MEDICINE
- Assessment, endoscopy, and treatment in patients with acute severe ulcerative colitis during the COVID-19 pandemic (PROTECT-ASUC): a multicentre, observational, case-control study
- (2021) Shaji Sebastian et al. Lancet Gastroenterology & Hepatology
- Risk of severe COVID‐19 in patients treated with IBD medications: a French nationwide study
- (2021) Antoine Meyer et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Adverse Events After SARS-CoV-2 mRNA Vaccination Among Patients With Inflammatory Bowel Disease
- (2021) Gregory J. Botwin et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Humoral and T-cell responses to SARS-CoV-2 vaccination in patients receiving immunosuppression
- (2021) Maria Prendecki et al. ANNALS OF THE RHEUMATIC DISEASES
- No Durable Impact of COVID-19 on Intestinal Disease Activity in Subjects With IBD
- (2021) Dana J. Lukin et al. Clinical Gastroenterology and Hepatology
- The natural history of COVID-19 in patients with inflammatory bowel disease
- (2021) Giorgos Bamias et al. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
- Impact of Medications on COVID-19 Outcomes in Inflammatory Bowel Disease: Analysis of Over 6,000 Patients from an International Registry
- (2021) Ryan C. Ungaro et al. GASTROENTEROLOGY
- Effectiveness of SARS-CoV-2 Vaccination in a Veterans Affairs Cohort of Patients With Inflammatory Bowel Disease With Diverse Exposure to Immunosuppressive Medications
- (2021) Nabeel Khan et al. GASTROENTEROLOGY
- Ultra-proactive Therapeutic Drug Monitoring of Infliximab Based on Point of Care Testing in Inflammatory Bowel Disease: Results of a Pragmatic Trial
- (2021) Peter Bossuyt et al. Journal of Crohns & Colitis
- Patient-led Remote IntraCapillary pharmacoKinetic Sampling (fingerPRICKS) for therapeutic drug monitoring in patients with inflammatory bowel disease
- (2021) Desmond Chee et al. Journal of Crohns & Colitis
- Adalimumab and infliximab impair SARS-CoV-2 antibody responses: results from a therapeutic drug monitoring study in 11422 biologic-treated patients
- (2021) Neil Chanchlani et al. Journal of Crohns & Colitis
- COVID‐19 outcomes in patients with inflammatory bowel diseases in Latin America: Results from SECURE‐IBD registry
- (2021) Natália S F Queiroz et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Lower incidence of COVID‐19 in patients with inflammatory bowel disease treated with non‐gut selective biologic therapy
- (2021) Sandro Ardizzone et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- CD8+ T cells contribute to survival in patients with COVID-19 and hematologic cancer
- (2021) Erin M. Bange et al. NATURE MEDICINE
- Tofacitinib in Patients Hospitalized with Covid-19 Pneumonia
- (2021) Patrícia O. Guimarães et al. NEW ENGLAND JOURNAL OF MEDICINE
- A machine learning approach identifies 5-ASA and ulcerative colitis as being linked with higher COVID-19 mortality in patients with IBD
- (2021) Satyaki Roy et al. Scientific Reports
- Long covid—mechanisms, risk factors, and management
- (2021) Harry Crook et al. BMJ-British Medical Journal
- COVID‐19 in gastroenterology: Where are we now? Current evidence on the impact of COVID‐19 in gastroenterology
- (2021) Fernando Magro et al. United European Gastroenterology Journal
- Hospitalisation for Drug Infusion Did Not Increase Levels of Anxiety and the Risk of Disease Relapse in Patients with Inflammatory Bowel Disease during COVID-19 Outbreak
- (2021) Lorenzo Bertani et al. Journal of Clinical Medicine
- COVID-19: Colorectal cancer endoscopic surveillance in IBD
- (2021) Shahida Din et al. Lancet Gastroenterology & Hepatology
- Incidence, outcomes, and impact of COVID‐19 on inflammatory bowel disease: propensity matched research network analysis
- (2021) Yousaf Hadi et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Antibody Responses After SARS-CoV-2 mRNA Vaccination in Adults With Inflammatory Bowel Disease
- (2021) Gil Y. Melmed et al. ANNALS OF INTERNAL MEDICINE
- The Omicron variant is highly resistant against antibody-mediated neutralization: Implications for control of the COVID-19 pandemic
- (2021) Markus Hoffmann et al. CELL
- COVID-19 Outcomes Among Racial and Ethnic Minority Individuals With Inflammatory Bowel Disease in the United States
- (2021) Manasi Agrawal et al. Clinical Gastroenterology and Hepatology
- Humoral Immune Response to Messenger RNA COVID-19 Vaccines Among Patients With Inflammatory Bowel Disease
- (2021) Michael D. Kappelman et al. GASTROENTEROLOGY
- COVID-19 Vaccination Is Safe and Effective in Patients With Inflammatory Bowel Disease: Analysis of a Large Multi-institutional Research Network in the United States
- (2021) Yousaf Bashir Hadi et al. GASTROENTEROLOGY
- Serologic Response to Coronavirus Disease 2019 (COVID-19) Vaccination in Patients With Immune-Mediated Inflammatory Diseases: A Systematic Review and Meta-analysis
- (2021) Atsushi Sakuraba et al. GASTROENTEROLOGY
- Lower Serologic Response to COVID-19 mRNA Vaccine in Patients With Inflammatory Bowel Diseases Treated With Anti-TNFα
- (2021) Hadar Edelman-Klapper et al. GASTROENTEROLOGY
- Intestinal Protein Characterisation of SARS-CoV-2 Entry Molecules ACE2 and TMPRSS2 in Inflammatory Bowel Disease (IBD) and Fatal COVID-19 Infection
- (2021) Milly J. McAllister et al. INFLAMMATION
- COVID-19 and Outcomes in Patients With Inflammatory Bowel Disease: Systematic Review and Meta-Analysis
- (2021) Kartikeya Tripathi et al. INFLAMMATORY BOWEL DISEASES
- Anti-SARS-CoV-2 Vaccination and Antibody Response in Patients With Inflammatory Bowel Disease on Immune-modifying Therapy: Prospective Single-Tertiary Study
- (2021) Karin Cerna et al. INFLAMMATORY BOWEL DISEASES
- Impact of SARS-CoV-2 Vaccination on Inflammatory Bowel Disease Activity and Development of Vaccine-Related Adverse Events: Results From PREVENT-COVID
- (2021) Kimberly N Weaver et al. INFLAMMATORY BOWEL DISEASES
- Management of Pregnant Women with Inflammatory Bowel Disease and COVID-19–Balancing Risks of Delayed Treatment Recommencement
- (2021) Ralley E Prentice et al. Journal of Crohns & Colitis
- Prior Immunosuppressive Therapy and Severe Illness Among Patients Diagnosed with SARS-CoV-2: a Community-Based Study
- (2021) Fernando S. Velayos et al. JOURNAL OF GENERAL INTERNAL MEDICINE
- A clinical case definition of post-COVID-19 condition by a Delphi consensus
- (2021) Joan B Soriano et al. LANCET INFECTIOUS DISEASES
- Correlates of protection against symptomatic and asymptomatic SARS-CoV-2 infection
- (2021) Shuo Feng et al. NATURE MEDICINE
- Waning Immune Humoral Response to BNT162b2 Covid-19 Vaccine over 6 Months
- (2021) Einav G. Levin et al. NEW ENGLAND JOURNAL OF MEDICINE
- Severe COVID-19 in inflammatory bowel disease patients in a population-based setting
- (2021) Rob H. Creemers et al. PLoS One
- Development and validation of multivariable prediction models for adverse COVID-19 outcomes in patients with IBD
- (2021) John Sperger et al. BMJ Open
- Clinical Outcomes of COVID-19 and Impact on Disease Course in Patients with Inflammatory Bowel Disease
- (2021) Panu Wetwittayakhlang et al. Canadian Journal of Gastroenterology and Hepatology
- Long COVID in Inflammatory Bowel Diseases
- (2021) Silvia Salvatori et al. Journal of Clinical Medicine
- Immunogenicity of BNT162b2 Vaccine in Patients with Inflammatory Bowel Disease on Infliximab Combination Therapy: A Multicenter Prospective Study
- (2021) Mohammad Shehab et al. Journal of Clinical Medicine
- Association Between Tumor Necrosis Factor Inhibitors and the Risk of Hospitalization or Death Among Patients With Immune-Mediated Inflammatory Disease and COVID-19
- (2021) Zara Izadi et al. JAMA Network Open
- Clinical presentation of COVID-19 in patients with inflammatory bowel disease: a systematic review and meta-analysis
- (2021) Anupam K. Singh et al. Intestinal Research
- Crohn’s and Colitis Canada’s 2021 Impact of COVID-19 and Inflammatory Bowel Disease in Canada: Risk Factors and Medications
- (2021) Laura E Targownik et al. Journal of the Canadian Association of Gastroenterology
- Crohn’s and Colitis Canada’s 2021 Impact of COVID-19 and Inflammatory Bowel Disease in Canada: Children and Expectant Mothers With Inflammatory Bowel Disease
- (2021) Eric I Benchimol et al. Journal of the Canadian Association of Gastroenterology
- Addition of azathioprine to the switch of anti-TNF in patients with IBD in clinical relapse with undetectable anti-TNF trough levels and antidrug antibodies: a prospective randomised trial
- (2020) Xavier Roblin et al. GUT
- A new coronavirus associated with human respiratory disease in China
- (2020) Fan Wu et al. NATURE
- A Novel Coronavirus from Patients with Pneumonia in China, 2019
- (2020) Na Zhu et al. NEW ENGLAND JOURNAL OF MEDICINE
- 2019 Novel Coronavirus Disease (COVID-19) in patients with Inflammatory Bowel Diseases
- (2020) Carlos Taxonera et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Plans to Reactivate Gastroenterology Practices Following the COVID-19 Pandemic: A Survey of North American Centers
- (2020) Vladimir M. Kushnir et al. Clinical Gastroenterology and Hepatology
- SARS-CoV-2 Testing, Prevalence, and Predictors of COVID-19 in Patients with Inflammatory Bowel Disease in Northern California
- (2020) John Gubatan et al. GASTROENTEROLOGY
- Endoscopy units and the COVID-19 Outbreak: A Multi-Center Experience from Italy
- (2020) Alessandro Repici et al. GASTROENTEROLOGY
- Corticosteroids, but not TNF Antagonists, are Associated with Adverse COVID-19 Outcomes in Patients With Inflammatory Bowel Diseases: Results from an International Registry
- (2020) Erica J. Brenner et al. GASTROENTEROLOGY
- AGA Clinical Practice Update on Management of Inflammatory Bowel Disease During the COVID-19 Pandemic: Expert Commentary
- (2020) David T. Rubin et al. GASTROENTEROLOGY
- Gastrointestinal endoscopy during the COVID-19 pandemic: an updated review of guidelines and statements from international and national societies
- (2020) Elio C. Castro Filho et al. GASTROINTESTINAL ENDOSCOPY
- GUIDANCE FOR RESUMING GI ENDOSCOPY AND PRACTICE OPERATIONS AFTER THE COVID-19 PANDEMIC
- (2020) Bruce Hennessy et al. GASTROINTESTINAL ENDOSCOPY
- Covid-19 and immunomodulation in IBD
- (2020) Markus F Neurath GUT
- Outcomes of COVID-19 in 79 patients with IBD in Italy: an IG-IBD study
- (2020) Cristina Bezzio et al. GUT
- Practice of endoscopy during COVID-19 pandemic: position statements of the Asian Pacific Society for Digestive Endoscopy (APSDE-COVID statements)
- (2020) Philip Wai Yan Chiu et al. GUT
- British Society of Gastroenterology guidance for management of inflammatory bowel disease during the COVID-19 pandemic
- (2020) Nicholas A Kennedy et al. GUT
- Expression of SARS-CoV-2 Entry Molecules ACE2 and TMPRSS2 in the Gut of Patients With IBD
- (2020) Juan F Burgueño et al. INFLAMMATORY BOWEL DISEASES
- Management of Acute Severe Ulcerative Colitis in a Pregnant Woman With COVID-19 Infection: A Case Report and Review of the Literature
- (2020) Melissa H Rosen et al. INFLAMMATORY BOWEL DISEASES
- Managing patients with rheumatic diseases during the COVID-19 pandemic: The French Society of Rheumatology answers to most frequently asked questions up to May 2020
- (2020) Christophe Richez et al. JOINT BONE SPINE
- Overview of guidance for endoscopy during the coronavirus disease 2019 pandemic
- (2020) Rashid N Lui et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Pediatric Crohn's Disease and Multisystem Inflammatory Syndrome in Children (MIS-C) and COVID-19 Treated with Infliximab
- (2020) Michael T. Dolinger et al. JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION
- Hyperinflammatory shock in children during COVID-19 pandemic
- (2020) Shelley Riphagen et al. LANCET
- Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, China
- (2020) Chaomin Wu et al. JAMA Internal Medicine
- Low frequency of COVID-19 in inflammatory bowel diseases
- (2020) Irene Marafini et al. DIGESTIVE AND LIVER DISEASE
- Collateral Effect of COVID-19 Pandemic on Hospitalizations and Clinical Outcomes in Gastrointestinal and Liver Diseases – A Territory-wide Observational Study in Hong Kong
- (2020) Louis HS. Lau et al. GASTROENTEROLOGY
- Risk of Severe COVID-19 in Patients with Inflammatory Bowel Disease in United States. A Multicenter Research Network Study.
- (2020) Shailendra Singh et al. GASTROENTEROLOGY
- Adaptations to the British Society of Gastroenterology guidelines on the management of acute severe UC in the context of the COVID-19 pandemic: a RAND appropriateness panel
- (2020) Shahida Din et al. GUT
- Impact of the COVID-19 pandemic on UK endoscopic activity and cancer detection: a National Endoscopy Database Analysis
- (2020) Matthew D Rutter et al. GUT
- Practical management of inflammatory bowel disease patients during the COVID ‐19 pandemic: expert commentary from the Gastroenterological Society of Australia Inflammatory Bowel Disease faculty
- (2020) Al‐Ani Aysha et al. INTERNAL MEDICINE JOURNAL
- Persistent Symptoms in Patients After Acute COVID-19
- (2020) Angelo Carfì et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Inflammatory bowel disease management during the COVID-19 outbreak: The 10 do's and don'ts from the ECCO-COVID Taskforce
- (2020) F Magro et al. Journal of Crohns & Colitis
- Zero COVID‐19 infection in inflammatory bowel disease patients: Findings from population‐based inflammatory bowel disease registries in Hong Kong and Taiwan
- (2020) Joyce Wing Yan Mak et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Corona Virus Disease 2019 and Paediatric Inflammatory Bowel Diseases
- (2020) Dan Turner et al. JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION
- SFED recommendations for IBD endoscopy during COVID-19 pandemic: Italian and French experience
- (2020) Federica Furfaro et al. Nature Reviews Gastroenterology & Hepatology
- Dexamethasone in Hospitalized Patients with Covid-19 — Preliminary Report
- (2020) NEW ENGLAND JOURNAL OF MEDICINE
- Endoscopy works during the pandemic of coronavirus COVID-19: recommendations by the Chinese Society of Digestive Endoscopy
- (2020) Ningli Chai et al. United European Gastroenterology Journal
- Endoscopy in inflammatory bowel diseases during the COVID-19 pandemic and post-pandemic period
- (2020) Marietta Iacucci et al. Lancet Gastroenterology & Hepatology
- The receptor binding domain of the viral spike protein is an immunodominant and highly specific target of antibodies in SARS-CoV-2 patients
- (2020) Lakshmanane Premkumar et al. Science Immunology
- Changes in the Number of US Patients With Newly Identified Cancer Before and During the Coronavirus Disease 2019 (COVID-19) Pandemic
- (2020) Harvey W. Kaufman et al. JAMA Network Open
- Are Patients With Inflammatory Bowel Disease at an Increased Risk of Developing SARS-CoV-2 than Patients Without Inflammatory Bowel Disease? Results From a Nationwide Veterans' Affairs Cohort Study
- (2020) Nabeel Khan et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Robust T Cell Immunity in Convalescent Individuals with Asymptomatic or Mild COVID-19
- (2020) Takuya Sekine et al. CELL
- Antigen-Specific Adaptive Immunity to SARS-CoV-2 in Acute COVID-19 and Associations with Age and Disease Severity
- (2020) Carolyn Rydyznski Moderbacher et al. CELL
- BENIGN EVOLUTION OF SARS-CoV2 INFECTIONS IN CHILDREN WITH INFLAMMATORY BOWEL DISEASE: RESULTS FROM TWO INTERNATIONAL DATABASES
- (2020) Erica J. Brenner et al. Clinical Gastroenterology and Hepatology
- African League Against Rheumatism (AFLAR) preliminary recommendations on the management of rheumatic diseases during the COVID-19 pandemic
- (2020) Richard Oluyinka Akintayo et al. CLINICAL RHEUMATOLOGY
- Expert Opinions on the Current Therapeutic Management of Inflammatory Bowel Disease during the COVID-19 Pandemic: Japan IBD COVID-19 Taskforce, Intractable Diseases, the Health and Labor Sciences Research
- (2020) Hiroshi Nakase et al. DIGESTION
- Management of paediatric IBD after the peak of COVID-19 pandemic in Italy: a position paper on behalf of the SIGENP IBD Working Group
- (2020) Serena Arrigo et al. DIGESTIVE AND LIVER DISEASE
- Asymptomatic Severe Acute Respiratory Syndrome Coronavirus 2 Infection in Patients With Inflammatory Bowel Disease Under Biologic Treatment
- (2020) Lorenzo Norsa et al. GASTROENTEROLOGY
- Intestinal inflammation modulates the expression of ACE2 and TMPRSS2 and potentially overlaps with the pathogenesis of SARS-CoV-2 related disease
- (2020) Mayte Suárez-Fariñas et al. GASTROENTEROLOGY
- Adaptations to the current ECCO/ESPGHAN guidelines on the management of paediatric acute severe colitis in the context of the COVID-19 pandemic: a RAND appropriateness panel
- (2020) Richard Hansen et al. GUT
- Effect of IBD medications on COVID-19 outcomes: results from an international registry
- (2020) Ryan C Ungaro et al. GUT
- Worldwide Management of Inflammatory Bowel Disease During the COVID-19 Pandemic: An International Survey
- (2020) Charles N Bernstein et al. INFLAMMATORY BOWEL DISEASES
- Immunosuppressive Therapy and Risk of COVID-19 Infection in Patients With Inflammatory Bowel Diseases
- (2020) Kristin E Burke et al. INFLAMMATORY BOWEL DISEASES
- Paediatric Inflammatory Multisystem Syndrome temporally associated with SARS-CoV-2 (PIMS-TS) in a patient receiving Infliximab therapy for Inflammatory Bowel Disease
- (2020) Joseph Meredith et al. Journal of Crohns & Colitis
- Prevalence and outcomes of COVID-19 among patients with inflammatory bowel disease – A Danish prospective population-based cohort study
- (2020) Mohamed Attauabi et al. Journal of Crohns & Colitis
- COVID-19 Pandemic: Which IBD Patients Need to Be Scoped—Who Gets Scoped Now, Who Can Wait, and how to Resume to Normal
- (2020) Siew C Ng et al. Journal of Crohns & Colitis
- Management of Pregnant Inflammatory Bowel Disease Patients During the COVID-19 Pandemic
- (2020) A De Lima-Karagiannis et al. Journal of Crohns & Colitis
- Guidance for Restarting Inflammatory Bowel Disease Therapy in Patients Who Withheld Immunosuppressant Medications During COVID-19
- (2020) Corey A Siegel et al. Journal of Crohns & Colitis
- Clinical Outcomes of Covid-19 in Patients with Inflammatory Bowel Disease: A Nationwide Cohort Study
- (2020) Lauranne A A P Derikx et al. Journal of Crohns & Colitis
- What we have to know about corticosteroids use during Sars-Cov-2 infection
- (2020) F. Ferraù et al. JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION
- High Immunogenicity to Influenza Vaccination in Crohn’s Disease Patients Treated with Ustekinumab
- (2020) Laura Doornekamp et al. Vaccines
- COVID-19 in IBD: The experience of a single tertiary IBD center
- (2020) Fernando Rizzello et al. DIGESTIVE AND LIVER DISEASE
- Characteristics and Outcomes of IBD Patients with COVID-19 on Tofacitinib Therapy in the SECURE-IBD Registry
- (2020) Manasi Agrawal et al. INFLAMMATORY BOWEL DISEASES
- Seroprevalence of SARS-CoV2 in IBD Patients Treated with Biologic Therapy
- (2020) Roberto Berte’ et al. Journal of Crohns & Colitis
- Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine
- (2020) Lindsey R. Baden et al. NEW ENGLAND JOURNAL OF MEDICINE
- Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine
- (2020) Fernando P. Polack et al. NEW ENGLAND JOURNAL OF MEDICINE
- Efficacy of dashboard driven dosing of infliximab in inflammatory bowel disease patients; a randomized controlled trial
- (2020) Anne S. Strik et al. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY
- Risk and outcomes of coronavirus disease (COVID-19) in patients with inflammatory bowel disease: a systematic review and meta-analysis
- (2020) Anupam Kumar Singh et al. United European Gastroenterology Journal
- Sixty-Day Outcomes Among Patients Hospitalized With COVID-19
- (2020) Vineet Chopra et al. ANNALS OF INTERNAL MEDICINE
- Risk of Serious and Opportunistic Infections Associated With Treatment of Inflammatory Bowel Diseases
- (2018) Julien Kirchgesner et al. GASTROENTEROLOGY
- Increased Risk of Influenza and Influenza-Related Complications Among 140,480 Patients With Inflammatory Bowel Disease
- (2018) Andrew Tinsley et al. INFLAMMATORY BOWEL DISEASES
- Respiratory Tract Infections in Patients With Inflammatory Bowel Disease: Safety Analyses From Vedolizumab Clinical Trials
- (2018) Brian G Feagan et al. Journal of Crohns & Colitis
- Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies
- (2017) Siew C Ng et al. LANCET
- Tofacitinib as Induction and Maintenance Therapy for Ulcerative Colitis
- (2017) William J. Sandborn et al. NEW ENGLAND JOURNAL OF MEDICINE
- Biologic Therapies and Risk of Infection and Malignancy in Patients With Inflammatory Bowel Disease: A Systematic Review and Network Meta-analysis
- (2016) Stefanos Bonovas et al. Clinical Gastroenterology and Hepatology
- Increased Risk of Pneumonia Among Patients With Inflammatory Bowel Disease
- (2013) Millie D Long et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Vedolizumab as Induction and Maintenance Therapy for Crohn's Disease
- (2013) William J. Sandborn et al. NEW ENGLAND JOURNAL OF MEDICINE
- Immune response to influenza A/H1N1 vaccine in inflammatory bowel disease patients treated with anti TNF-α agents: Effects of combined therapy with immunosuppressants
- (2012) G. Andrisani et al. Journal of Crohns & Colitis
- Switch to adalimumab in patients with Crohn's disease controlled by maintenance infliximab: prospective randomised SWITCH trial
- (2011) Gert Van Assche et al. GUT
- Immunogenicity and safety of influenza vaccination in children with inflammatory bowel disease
- (2011) Jennifer C.C. deBruyn et al. INFLAMMATORY BOWEL DISEASES
- Effects of immunosuppression on immune response to pneumococcal vaccine in inflammatory bowel disease: A prospective study*
- (2011) Gionata Fiorino et al. INFLAMMATORY BOWEL DISEASES
- Immunosuppression Impairs Response to Pneumococcal Polysaccharide Vaccination in Patients With Inflammatory Bowel Disease
- (2009) Gil Y Melmed et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now